 Source: AscannioShutterstock.com Novavax NASDAQ: NVAX stock closed higher by 6.7 today. Currently, the company is slated to share positive data from Phase 1 and 2 trials concerning its Covid-19-Influenza Combination CIC vaccine at the World Vaccine Congress WVC Europe 2022 event on Oct. 13. 